Prostate
Cancer

Oncology Solutions

The Patient Journey


One in seven men will be diagnosed with prostate cancer,1 with 1.2 million new cases in 2018.2 According to the American Cancer Society the overall 5-year survival rate is 99 percent for all stages of prostate cancer, however when diagnosed at stage IVB, the 5-year survival rate drops significantly to 29 percent.3

  • SIGNA™ Architect AIR™ Edition

    Our premium 3.0T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.

  • Computed Tomography

    Your need for quality patient care at low dose with greater productivity and affordability is more important than ever. That’s why we design CT systems that help...

  • SIGNA™ PETMR with QuantWorks

    Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

The latest in Oncology


INSIGHTS
1. Prostate Cancer Risk Factors [Internet]. WebMD. 2018 [cited 5 November 2018]. Available from: https://www.webmd.com/prostate-cancer/guide/prostate-cancer-risk-factors
2. Prostate cancer statistics [Internet]. World Cancer Research Fund. 2018 [cited 5 November 2018]. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/prostate-cancer-statistics
3. Survival Rates for Prostate Cancer [Internet]. Cancer.org. 2018 [cited 5 November 2018]. Available from: https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html#written_by Patel AR, Klein EA.

JB04823XX